Welcome to our dedicated page for Chiron Real Estate SEC filings (Ticker: GMRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Chiron Real Estate's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Chiron Real Estate's regulatory disclosures and financial reporting.
Global Medical REIT (NYSE:GMRE) Form 4 discloses that newly appointed CEO and President Mark Okey Decker Jr. purchased 160,000 common shares on 24-25 June 2025 at a weighted average price of about $6.52, committing roughly $1.0 million of personal capital. Following the transactions, he directly owns 160,000 shares.
On 23 June 2025 he also received 158,730 Long-Term Incentive Plan (LTIP) units, exchangeable one-for-one for common stock after vesting on the third anniversary of grant.
- Transaction code: P (open-market purchases)
- Ownership form: Direct
- No Rule 10b5-1 plan indicated
The >$1 million insider buy by the CEO is a potentially positive signal of management confidence and tighter alignment with shareholder interests.
Form 3 filing overview: Global Medical REIT Inc. (GMRE) submitted an Initial Statement of Beneficial Ownership (Form 3) on 25 June 2025 for Mark Okey Decker Jr., who is listed as both Director and President & CEO.
Key details
- Date of event: 23 June 2025
- Securities owned: None – the filing explicitly states “No securities are beneficially owned.”
- Signatory: /s/ Jamie Barber acting under Power of Attorney dated 23 June 2025.
The document satisfies Section 16(a) initial reporting requirements and indicates the new executive currently holds zero GMRE common shares or derivative securities, leaving open the possibility of future insider acquisitions that would require subsequent Form 4 disclosures.
Global Medical REIT Inc. (NYSE: GMRE) filed an 8-K disclosing a CEO transition effective 23 Jun 2025. Jeffrey M. Busch has been removed as Chief Executive Officer and President and will remain non-executive Chairman. The Board simultaneously appointed Mark O. Decker, Jr. (age 49) as CEO, President and Board member, expanding the Board from seven to eight seats.
The filing provides a detailed three-year employment agreement between Inter-American Management LLC and Mr. Decker:
- Base salary: $700,000 per year.
- Target annual cash bonus: ≥100 % of base salary, prorated for 2025 (60 % cash / 40 % LTIP Units).
- Equity incentives: one-time $1 million LTIP award on the Effective Date; $1.2 million target LTIP award for 2026.
- Relocation stipend: $75,000.
Severance for a "Qualifying Termination" equals 2× (base salary + greater of target or prior-year bonus), pro-rated bonus, accelerated vesting of equity, and up to 18 months of subsidized health coverage. Enhanced benefits (up to 3× multiplier) apply upon qualifying terminations linked to a change in control. Definitions of "good reason" and "cause" are standard for REIT executives.
Mr. Decker’s prior roles include Managing Partner at Proterra Value Investors (2023-2025) and CEO/CIO of Centerspace (NYSE: CSR, 2017-2023). The filing states no family relationships or related-party transactions.